Osteogenic differentiation, the process by which bone marrow mesenchymal stem/stromal (a.k.a. skeletal stem) cells and osteoprogenitors form osteoblasts, is a critical event for bone formation during development, fracture repair, and tissue maintenance. Extra cellular and intracellular signaling pathways triggering osteogenic differentiation are relatively well known; however, the ensuing change in cell energy metabolism is less clearly defined. We and others have previously reported activation of mitochondria during osteogenic differentiation. To further elucidate the involved bioenergetic mechanisms and triggers, we tested the effect of osteogenic media containing ascorbate and β-glycerol phosphate, or various osteogenic hormones and growth factors on energy metabolism in long bone (ST2)- and calvarial bone (MC3T3-E1)-derived osteoprogenitors. We show that osteogenic media and differentiation factors, Wnt3a and BMP2, stimulate mitochondrial oxidative phosphorylation (OxPhos) with little effect on glycolysis. The activation of OxPhos occurs acutely, suggesting a metabolic signaling change rather than protein expression change. To this end, we found that the observed mitochondrial activation is Akt dependent. Akt is activated by osteogenic media, Wnt3a, and BMP2, leading to increased phosphorylation of various mitochondrial Akt targets, a phenomenon known to stimulate OxPhos. In sum, our data provide comprehensive analysis of cellular bioenergetics during osteoinduction in cells of two different origins (mesenchyme vs neural crest) and identify Wnt3a and BMP2 as physiological stimulators of mitochondrial respiration through Akt activation.
Get full access to this article
View all access options for this article.
References
1.
NunnariJ and SuomalainenA. (2012). Mitochondria: in sickness and in health. Cell, 148:1145–1159.
2.
McBrideHM, NeuspielM and WasiakS. (2006). Mitochondria: more than just a powerhouse. Curr Biol, 16:R551.
3.
SchorrS and van der LaanM. (2018). Integrative functions of the mitochondrial contact site and cristae organizing system. Semin Cell Dev Biol, 76:191–200.
4.
VarumS, RodriguesAS, MouraMB, MomcilovicO, EasleyCAIV, Ramalho-SantosJ, van HoutenB and SchattenG. (2011). Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One, 6:e20914.
5.
SandhirR, HalderA and SunkariaA. (2017). Mitochondria as a centrally positioned hub in the innate immune response. Biochim Biophys Acta - Mol Basis Dis, 1863:1090–1097.
6.
CherryC, ThompsonB, SaptarshiN, WuJ and HohJ. (2016). 2016: A “Mitochondria” Odyssey. Trends Mol Med, 22:391–403.
7.
VafaiSB and MoothaVK. (2012). Mitochondrial disorders as windows into an ancient organelle. Nature, 491:374–383.
8.
BiancoP, CaoX, FrenettePS, MaoJJ, RobeyPG, SimmonsPJ and WangC-Y. (2013). The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med, 19:35–42.
9.
MotylKJ, GunturAR, CarvalhoAL and RosenCJ. (2017). Energy Metabolism of Bone. Toxicol Pathol, 45:887–893.
10.
ChenC-T, ShihY-RV, KuoTK, LeeOK and WeiY-H. (2008). Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells, 26:960–968.
11.
GunturAR, LePT, FarberCR and RosenCJ. (2014). Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass. Endocrinology, 155:1589–1595.
12.
ShumLC, WhiteNS, MillsBN, de M BentleyKL and EliseevRA. (2016). Energy metabolism in mesenchymal stem cells during osteogenic differentiation. Stem Cells Dev, 25:114–122.
13.
SharesBH, BuschM, WhiteN, ShumL and EliseevRA. (2018). Active mitochondria support osteogenic differentiation by stimulating-Catenin acetylation. J Biol Chem, 293:16019–16027.
14.
QuartoN, WanDC, KwanMD, PanettaNJ, LiS and LongakerMT. (2010). Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones. J Bone Miner Res, 25:1680–1694.
15.
EsenE, ChenJ, KarnerCM, OkunadeAL, PattersonBW and LongF. (2013). WNT-LRP5 signaling induces warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab, 17:745–755.
16.
GunturAR, GerencserAA, LePT, DeMambroVE, BornsteinSA, MookerjeeSA, MaridasDE, ClemmonsDE, BrandMD and RosenCJ. (2018). Osteoblast-like MC3T3–E1 Cells Prefer Glycolysis for ATP Production but Adipocyte-like 3T3–L1 cells prefer oxidative phosphorylation. J Bone Miner Res, 33:1052–1065.
17.
PattappaG, HeywoodHK, de BruijnJD and LeeDA. (2011). The metabolism of human mesenchymal stem cells during proliferation and differentiation. J Cell Physiol, 226:2562–2570.
18.
KomarovaSV, AtaullakhanovFI and GlobusRK. (2000). Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol, 279:C1220–C1229.
19.
YuY, NewmanH, ShenL, SharmaD, HuG, MirandoAJ, ZhangH, KnudsenE, ZhangGF, HiltonMJ and KarnerCM. (2019). Glutamine metabolism regulates proliferation and lineage allocation in skeletal stem cells. Cell Metab, 29:966–978.e4.
20.
GanzJ, KaslinJ, FreudenreichD, MachateA, GeffarthM and BrandM. (2011). Subdivisions of the adult zebrafish subpallium by molecular marker analysis Julia Ganz. J Comp Neurol, 520:633–655.
21.
ForniMF, PeloggiaJ, TrudeauK, ShirihaiO and KowaltowskiAJ. (2016). Murine mesenchymal stem cell commitment to differentiation is regulated by mitochondrial dynamics. Stem Cells, 34:743–755.
22.
MetsaluT and ViloJ. (2015). ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res, 43:W566–W570.
23.
JolliffeI. (2014). Principal Component Analysis. In: Wiley StatsRef: Statistics Reference Online. John Wiley & Sons, Ltd, Chichester, United Kingdom.
24.
OtsukaE, YamaguchiA, HiroseS and HagiwaraH. (1999). Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol Physiol, 277:C132–C138.
25.
WangD, ChristensenK, ChawlaK, XiaoG, KrebsbachPH and FranceschiRT. (1999). Isolation and Characterization of MC3T3–E1 Vivo Differentiation/Mineralization Potential. J Bone Miner Res, 14:893–903.
26.
RastogiA, JoshiP, ContrerasE and GamaV. (2019). Remodeling of mitochondrial morphology and function: an emerging hallmark of cellular reprogramming. Cell Stress, 3:181–194.
27.
KwonIK, LeeSC, HwangYS and HeoJS. (2015). Mitochondrial function contributes to oxysterol-induced osteogenic differentiation in mouse embryonic stem cells. Biochim Biophys Acta, 1853:561–572.
28.
RaucciA, BellostaP, GrassiR, BasilicoC and MansukhaniA. (2008). Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol, 215:442–451.
29.
BetzC, StrackaD, Prescianotto-BaschongC, FriedenM, DemaurexN and HallMN. (2013). MTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci U S A, 110:12526–12534.
30.
BijurGN and JopeRS. (2003). Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem, 87:1427–1435.
Scarpulla RC. (2008). Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev, 88:611–638.
34.
GottliebRA and BernsteinD. (2016). Mitochondrial remodeling: rearranging, recycling, and reprogramming. Cell Calcium, 60:88–101.
35.
Wilson-FritchL, BurkartA, BellG, MendelsonK, LeszykJ, NicoloroS, CzechM and CorveraS. (2003). Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol, 23:1085–1094.
36.
DivakaruniAS and BrandMD. (2011). The regulation and physiology of mitochondrial proton leak. Physiology (Bethesda), 26:192–205.
37.
CunhaFM, Caldeira da SilvaCC, CerqueiraFM and KowaltowskiAJ. (2011). Mild mitochondrial uncoupling as a therapeutic strategy. Curr Drug Targets, 12:783–789.
LuJ, QuS, YaoB, XuY, JinY, ShiK, ShuiY, PanS, ChenL and MaC. (2016). Osterix acetylation at K307 and K312 enhances its transcriptional activity and is required for osteoblast differentiation. Oncotarget, 7:37471–37486.
43.
EirakuN, ChibaN, NakamuraT, AmirMS, SeongC, OhnishiT, KusuyamaJ, NoguchiK and MatsuguchiT. (2019). BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts. FASEB J, 33:12124–12134.
44.
LingL, DombrowskiC, FoongKM, HauptLM, SteinGS, NurcombeV, Van WijnenAJ and CoolSM. (2010). Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway. J Biol Chem, 285:26233–26244.
45.
DemetriusL. (2005). Of mice and men. EMBO Rep, 6:S39.
46.
Jilka RL. (2013). The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci, 68:1209–1217.
47.
GilloolyJF, BrownJH, WestGB, SavageVM and CharnovEL. (2001). Effects of size and temperature on metabolic rate. Science (80-), 293:2248–2251.
48.
YuanR, TsaihSW, PetkovaSB, EvsikovaCM, XingS, MarionMA, BogueMA, MillsKD, PetersLL, BultCJ, RosenCJ, SundbergJP, HarrisonDE, ChurchillGA and PaigenB. (2009). Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell, 8:277–287.
JilkaRL, O'BrienCA, AliAA, RobersonPK, WeinsteinRS and ManolagasSC. (2009). Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone, 44:275–286.
51.
WeinsteinRS, JilkaRL, Michael ParfittA and ManolagasSC. (1998). Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone. J Clin Invest, 102:274–282.
52.
ParfittAM, HanZH, PalnitkarS, RaoDS, ShihMS and NelsonD. (1997). Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res, 12:1864–1873.
53.
LelovasPP, XanthosTT, ThormaSE, LyritisGP and DontasIA. (2008). The laboratory rat as an animal model for osteoporosis research. Comp Med, 58:424–430.
54.
Parfitt AM. (1994). Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem, 55:273–286.
55.
SchneiderP, KruckerT, MeyerE, Ulmann-SchulerA, WeberB, StampanoniM and MüllerR. (2009). Simultaneous 3D visualization and quantification of murine bone and bone vasculature using micro-computed tomography and vascular replica. Microsc Res Tech, 72:690–701.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
